Jing Gong
- Pharmacology top 2%
- Berberine and alkaloids research 11
- Pharmacology top 2%
- Berberine and alkaloids research 11
- Nephrology top 5%
- Cancer Research top 10%
- Cancer Genomics and Diagnostics 5
-
- Natural Antidiabetic Agents Studies 6
-
- COVID-19 Clinical Research Studies 6
-
- Pancreatic function and diabetes 6
-
- Glioma Diagnosis and Treatment 5
-
- Aquaculture disease management and microbiota 5
- Invertebrate Immune Response Mechanisms 5
- Cited by
- PharmacologyNephrology
- Journals
- Frontiers in Pharmacology (6 papers)Evidence-based Complementary and Alternative Medicine (6 papers)Phytomedicine (4 papers)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Jing Gong
94 papers receiving 2.9k citations
Peers
Comparison fields: 5 of 138
- Pharmacology 374
- Pharmacology 186
- Nephrology 137
- Cancer Research 261
- Endocrinology, Diabetes and Metabolism 278
Countries citing papers authored by Jing Gong
This map shows the geographic impact of Jing Gong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jing Gong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jing Gong more than expected).
Fields of papers citing papers by Jing Gong
This network shows the impact of papers produced by Jing Gong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jing Gong. The network helps show where Jing Gong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Jing Gong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 4 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 3 | |
| 5 | 2022 | 5 | |
| 6 | 2021 | 28 | |
| 7 | 2021 | 30 | |
| 8 | 2020 | 45 | |
| 9 | 2020 | 34 | |
| 10 | 2020 | 3 | |
| 11 | 2020 | 24 | |
| 12 | 2019 | 28 | |
| 13 | 2019 | 17 | |
| 14 | 2019 | 164 | |
| 15 | 2018 | 16 | |
| 16 | 2017 | 50 | |
| 17 | 2014 | 69 | |
| 18 | 2013 | 11 | |
| 19 | 2011 | 5 | |
| 20 | 2010 | 104 |
About Jing Gong
Jing Gong is a scholar working on Pharmacology, Endocrinology, Diabetes and Metabolism and Pulmonary and Respiratory Medicine, having authored 101 papers that have together received 2.9k indexed citations. Recurring topics across this work include Berberine and alkaloids research (11 papers), Natural Antidiabetic Agents Studies (6 papers), COVID-19 Clinical Research Studies (6 papers), Pancreatic function and diabetes (6 papers), Glioma Diagnosis and Treatment (5 papers), Cancer Genomics and Diagnostics (5 papers), Aquaculture disease management and microbiota (5 papers) and Invertebrate Immune Response Mechanisms (5 papers). The work is most often cited by research in Pharmacology (374 citations), Pharmacology (186 citations) and Nephrology (137 citations). Jing Gong has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Fuer Lu, Hui Dong, Ke Fang, Dingkun Wang, Zhaoyi Huang, Fen Yuan, Lijun Xu, Qingsong Xia, Meilin Hu and Jingbin Li. Their work appears in journals such as Frontiers in Pharmacology, Evidence-based Complementary and Alternative Medicine, Phytomedicine, PLoS ONE and Fish & Shellfish Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.